HIV Drug Delivers Outstanding Results in Lancet Published Study

A new drug that has a significant influence on the likelihood of being infected with HIV is being strongly promoted by experts. Pre-exposure prophylaxis (PrEP) is being heralded as a massive breakthrough in treating HIV and AIDS, after researchers in a UK-based study found that it decreased infections by 86 per cent among gay men at high risk. Scientists involved in the study opined that the NHS simply “cannot afford to ignore” this HIV treatment. Having carried out a trial at 13 sexual health... Readmore

ABPI and Department of Health to Make £209 Million PPRS Payment

The ABPI and the Department of Health have announced their intention to underwrite the growth in the medicines bill for the second quarter of 2015. This initiative will be taken under the Pharmaceutical Price Regulation Scheme (PPRS) that was agreed last year. The PPRS is a purely voluntary agreement between the two parties involved, although the existing understanding between the Department of Health and ABPI will run until the end of 2018, having come into effect on 1st January, 2014. Under... Readmore

Cancer Drugs Fund in England To Delist 16 Medicines

The Cancer Drugs Fund in England has announced that it is to effectively eliminate a raft of medicines that have previously been utilised in cancer treatment. This will effect 16 medicines that have previously been used in no less than 23 cancer treatments. With this latest decision, the Cancer Drugs Fund has taken the radical action of effectively more than halving the number of treatments it covers. The fund had suffered from repeated budgetary difficulties, and this has been the primary motivation... Readmore

Moody’s Report Paints Optimistic Picture of Global Pharma Industry

According to a newly released report from Moody’s, the industrial outlook for the global pharmaceutical industry looks to be extremely healthy. Although the pharmaceutical industry will experience pricing pressure over the next 12 to 18 months, the success of new products will more than offset this issue. Key European pharmaceutical manufacturers such as AstraZeneca are predicted to play a major role in the industry going forward. Moody’s also suggests that oncology will be the largest growth... Readmore

Survey Outlines Shocking Level of Data Loss in Pharma Sector

Considering the sensitivity of data protection and related topics in the existing client, a new survey provides a damning indictment of the pharmaceutical sector. According to the Crown Records Management / Censuswide Survey, 60 per cent of pharmaceutical companies have lost important data, and nearly one-in-four have been successfully breached by hackers. The survey which quizzed IT decision-makers at UK companies which boast more than 200 employees will of serious concern, particularly owing... Readmore

NHS Employers agree changes to CPCF for 2015/16

The NHS Employers organisation has reached agreement on a number of changes to the Community Pharmacy Contractual Framework (CPCF) in return for a funding package of £2.8bn for 2015/16. The agreed changes to the CPCF follow complex but constructive negotiations between all the interested parties (NHS Employers, the Pharmaceutical Services Negotiating Committee (PSNC) and NHS England). NHS Employers and PSNC have agreed to a new advanced service for influenza vaccinations. Adult patients, aged... Readmore

Patient-centred approach to innovation and clinical development proposed by BIA and MHRA

Collaborative approaches to supporting innovation and to facilitating clinical development and timely access to new treatments and vaccines for patients were unveiled in a new report this week. The report, from the UK BioIndustry Association (BIA) and Medicines and Healthcare products Regulatory Agency (MHRA) follows their annual conference - ‘Pathway of Innovation from Research to Patients’ – in London last month. The event was attended by over 140 delegates from patients’ groups,... Readmore

ABPI announces last aggregate payments to healthcare professionals

The Association of the British Pharmaceutical Industry (ABPI) today (15 July) announced the last disclosure of aggregate payments from the pharmaceutical industry to healthcare professionals before the new, individual payments disclosure database becomes operational in 2016. New figures show that payments from the pharmaceutical industry to doctors, nurses and other healthcare professionals during 2014 are estimated to be around £41m across 50 ABPI member companies. This is the last year that... Readmore

Pharmacists recruited by GP practices to help ease workload

250 clinical pharmacists are to be recruited to GP practices to provide direct patient care and help to ease workload NHS England has announced. The £15m, three-year pilot project - part of the GP workforce 10-point plan agreed between the BMA GPs committee, Royal College of GPs, NHS England and Health Education England - will see pharmacists support about one million patients with self-limiting illnesses or long-term conditions. To be able to take part in the pilot GP practices will have... Readmore

One third of pharmaceutical sector know nothing about new data protection regulations finds new survey

Pharmaceutical professionals across the UK are in danger of underestimating the huge changes that lie ahead in data protection – after a survey revealed almost one third aren’t even aware of the forthcoming European General Data Protection Regulation. Carried out by information management experts Crown Records Management, the survey of IT decision-makers at UK companies with more than 200 employees tested how well prepared businesses are for the changes. The results found that: (i) almost... Readmore

New vaccination programmes launched to protect against meningitis and septicaemia

Two vaccination programs - MenB and MenACWY – to protect babies and young people against the meningococcal bacterium will be launched in the summer the Department of Health has announced. From August 2015 all 17 and 18 year olds in school year 13 will be offered a combined vaccine that protects against the A, C, W and Y strains of meningococcal disease. The vaccine is particularly important for those who are heading off to university, as they are at greater risk. The vaccine will also be available... Readmore

WHO study highlights new medicines affordability issues in Europe

Increasing numbers of new medicines in Europe are causing affordability issues for governments according to a new study released today by the WHO Regional Office for Europe. The WHO study demonstrates the extent of the problem by highlighting the fact that few countries in the WHO European Region have structures in place to evaluate the cost–effectiveness of new drugs, which in turn impacts the value assessment and decision-making process. The report, ‘Access to new medicines in Europe:... Readmore
This site uses cookies. Find out more about this site’s cookies.